TrialJAMA cardiology2025

Olpasiran, Oxidized Phospholipids, and Systemic Inflammatory Biomarkers: Results From the OCEAN(a)-DOSE Trial.

Robert S Rosenson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.